Delivery Order SPE2DB22D2214-SPE2DB25FS5ZY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,569.98 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 100 mg tablets in quantities of 60 units, with a ceiling value of $4,082.11. This contract represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,443.28 on July 28, 2025, for the supply of Briviact 100 mg tablets in a 60-count package. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to compete in the...
- On July 30, 2025, the Defense Logistics Agency awarded a delivery order valued at $2,801.62 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract with DLA Troop Support Medical. The order is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a $1,905.41 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 25 mg on July 21, 2025, with a completion date of July 22, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,002.64 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Briviact 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,653.35 to AmerisourceBergen Drug Corp for Briviact 25 mg tablets (60-count units) on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $2,789.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, a psychiatric medication. This award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical distributor will perform the work at its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,316.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Briviact 100 mg, a medication used in the treatment of psychiatric conditions. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order under a larger pharmaceutical supply agreement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a $2,814.41 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,160,678 units of the medication Briviact 50 mg tablets, with a completion date of May 7, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5ZYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $1,057.82. This firm fixed-price delivery order, which is not set-aside, represents a competitive award to support federal medical procurement needs. The contract is set to complete by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The underlying IDC serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a critical vendor for federal medical supply chain operations across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |